Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Is Bevacizumab (Avastin) Safe And Effective As Adjuvant Chemotherapy For Adult Patients With Stage Iiib Or Iv Non-Small Cell Lung Carcinoma (Nsclc)?, Ashley R. De Kleine
Is Bevacizumab (Avastin) Safe And Effective As Adjuvant Chemotherapy For Adult Patients With Stage Iiib Or Iv Non-Small Cell Lung Carcinoma (Nsclc)?, Ashley R. De Kleine
PCOM Physician Assistant Studies Student Scholarship
OBJECTIVE: The objective of this selective EBM review is to determine whether or not bevacizumab (avastin) is safe and effective as adjuvant chemotherapy for adult patients with stage IIIb or IV non-small cell lung carcinoma (NSCLC).
STUDY DESIGN: Review of three randomized controlled trials (RCT) published in 2006, 2009, and 2011, all English language.
DATA SOURCES: Two randomized, double-blind, controlled clinical trials comparing bevacizumab to placebo as adjunctive chemotherapy, and one RCT comparing bevacizumab as adjunctive chemotherapy versus the use of no adjunctive chemotherapy. All articles were found using PubMed, Medline, and OVID.
OUTCOMES MEASURED: Overall …